Supreme Court of the United States
FDA v. Alliance for Hippocratic Medicine
June 13, 2024602 U.S. 367
Summary
The Supreme Court held that the pro‑life doctors and medical associations lack Article III standing to challenge the FDA's 2016 and 2021 regulatory changes to mifepristone, and therefore reversed the Fifth Circuit and remanded for further proceedings.
Holding
- Whether the plaintiffs have Article III standing to challenge the FDA's 2016 and 2021 regulatory actions concerning mifepristone.. The plaintiffs lack Article III standing; their claims are barred.
Docket 23-235
Cited authorities
- 21 C.F.R. § 314.50
- 21 U.S.C. § 355
- 21 C.F.R. §§ 201.5
- 21 U.S.C. § 355
- 17 Suffolk U. L. Rev. 881
- 42 Duke L.J. 1219
- 322 JAMA 1918
- Fed. R. Civ. P. 23
Cited by
- Murthy v. Missouri
- Corner Post, Inc. v. Board of Governors
- Earthgrains Baking Companies v. Sycamore Family Bakery
- American Educational Research Association v. U.S. Department of Education
- T&R Properties, Inc v. Berlin Township
- A Vision for You, LLC v. the City of Memphis
- Poppleton Now Community Association, Inc. v. La Cite Development, LLC
- LSP Transmission Holdings II, LLC v. Commonwealth Edison Company of Indiana, Inc.